Amiodarone has greater efficacy than dronedarone for the maintenance of sinus rhythm in patients with atrial fibrillation (AF), whereas dronedarone has a better safety profile that could result in ...

March 15, 2010 (Atlanta, Georgia) — Patients on amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation (AF) who are looking to switch to dronedarone (Multaq ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. Dronedarone, a highly touted drug targeted at atrial fibrillation ...

Despite initial hopes that dronedarone would cause fewer side effects than amiodarone, the studies submitted to the FDA do not confirm that, the researchers conclude. "We believe that dronedarone ...

Amiodarone is effective in maintaining sinus rhythm in atrial fibrillation but is associated with potentially serious toxic effects. Dronedarone is a new antiarrhythmic agent pharmacologically ...

Boston, MA - Dronedarone (Sanofi-Aventis)—dubbed the "son of amiodarone"—is better than placebo at maintaining sinus rhythm in patients with atrial fibrillation (AF) and at reducing ...

Dronedarone is a novel antiarrhythmic drug with electrophysiological properties that are similar to those of amiodarone, but it does not contain iodine and thus does not cause iodine-related ...

What is amiodarone used for? Amiodarone is commonly used to prevent and treat certain types of serious (and sometimes life-threatening) arrhythmias called ventricular fibrillation and ventricular ...

“Designed as a non-iodinated congener of amiodarone with less tissue accumulation, dronedarone has been previously shown to increase mortality among hospitalized decompensated patients with HF ...

The Appraisal Committee considered evidence submitted by the manufacturer of dronedarone and a review of this submission by the Evidence Review Group (ERG). The main clinical evidence on dronedarone ...

The Appraisal Committee considered evidence submitted by the manufacturer of dronedarone and a review of this submission by the Evidence Review Group (ERG). The main clinical evidence on dronedarone ...